Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model

[1]  Z. Nahleh,et al.  Allogeneic hematopoietic stem cell transplantation: complications and results. , 2002, Archives of internal medicine.

[2]  I. Gotsman,et al.  Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens – bystander effect , 2001, The Journal of pathology.

[3]  I. Gotsman,et al.  Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. , 2001, The Journal of pharmacology and experimental therapeutics.

[4]  R. Beinart,et al.  Induction of oral tolerance towards hepatitis B envelope antigens in a murine model. , 2000, Antiviral research.

[5]  A. Nagler,et al.  Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model , 2000 .

[6]  N. Chowdhury,et al.  Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes , 2000, American Journal of Gastroenterology.

[7]  A. Nagler,et al.  Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice , 2000, Hepatology.

[8]  A. Franchi,et al.  A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. , 1999, American journal of clinical pathology.

[9]  M. Ott,et al.  Oral tolerization to adenoviral proteins permits repeated adenovirus‐mediated gene therapy in rats with pre‐existing immunity to adenoviruses , 1998, Hepatology.

[10]  S. Strobel,et al.  Immune responses to dietary antigens: oral tolerance. , 1998, Immunology today.

[11]  G. Hill,et al.  Cytokine cascades in acute graft-versus-host disease. , 1997, Transplantation.

[12]  A. Nagler,et al.  Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. , 1997, Journal of hepatology.

[13]  H. Weiner.  Oral tolerance: immune mechanisms and treatment of autoimmune diseases. , 1997, Immunology today.

[14]  G. Droguett,et al.  Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. , 1997, The Journal of clinical investigation.

[15]  S. Stepkowski,et al.  Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules. , 1996, Transplantation.

[16]  M. Neurath,et al.  Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance , 1996, The Journal of experimental medicine.

[17]  J. Ferrara.  Cytokine Inhibitors and Graft‐versus‐Host Disease , 1995, Annals of the New York Academy of Sciences.

[18]  V. Barak,et al.  ELEVATED INFLAMMATORY CYTOKINE LEVELS IN BONE MARROW GRAFT REJECTION , 1995, Transplantation.

[19]  H. Weiner,et al.  Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. , 1995, The American journal of pathology.

[20]  C. Howell,et al.  Liver T cell subsets and adhesion molecules in murine graft-versus-host disease. , 1995, Bone marrow transplantation.

[21]  C. Howell,et al.  Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma. , 1992, Cellular immunology.

[22]  Rachel L. Mistur,et al.  Graft-Versus-Host Disease , 2016 .

[23]  J. Woodruff,et al.  The pathology of the graft-versus-host reaction (GVHR) in adults receiving bone marrow transplants. , 1976, Transplantation Proceedings.

[24]  A. Fischer,et al.  Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation. , 2002, Seminars in hematology.

[25]  A. Nagler,et al.  Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. , 2000, Blood.

[26]  G. Vogelsang.  Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment. , 1997, Cancer treatment and research.

[27]  W. Krenger,et al.  Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.

[28]  G. Wang,et al.  Induction of the , 1996 .

[29]  R. Puri,et al.  Human Cytokines: Their Role in Disease and Therapy , 1995 .

[30]  A. Nagler,et al.  Cytokine dysregulation in chronic graft versus host disease. , 1995, Leukemia & lymphoma.